ClinicalTrials.gov NCT01731236
GLP-1 receptor agonists are positioned as one of the pharmacotherapeutic options that can contribute to addressing the high unmet medical need characterizing several prevalent aging-related diseases, making them ideal for our longevity-focused approach
GLP-1 (glucagon-like peptide-1) receptor agonists, such as liraglutide, semaglutide, and dulaglutide, are medications commonly used to help manage T2D and aid in weight loss
"Other trademark licensing laws and regulations also exist that give the DoD, each Military Service, and other DoD Components authorization to protect and license their names, insignia, seals, symbols, phrases, and similar identifiers," it says